The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028. More Info:- https://www.imarcgroup.com/biobanking-market

1. Global Biobanking
Market Research and
Forecast Report 2023-
2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Biobanking Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast
2023-2028," the global biobanking market size reached US$ 57.5 Billion in
2022.
Biobanking refers to the procedure of collecting and preserving human
biospecimens that can be further used for diagnosis, biodiversity studies, and
research. These specimens are stored for several years and are used by
multiple researchers for cross-purpose research studies and to improve the
understanding of health and different diseases.
Over the years, biobanking has become a vital resource in medical research,
supporting various types of contemporary research like genomics and
personalized medicine.
Request for a PDF sample of this report:
https://www.imarcgroup.com/biobanking -market/requestsample

4. Report Description
Global Biobanking Market Trends:
The market is primarily driven by the growing prevalence of infectious and chronic diseases as biobanking is
extensively used to develop diagnostics that can accurately and quickly identify pathogens. In addition, the
escalating demand for regenerative medicine and personalized treatment represents another major growth-
inducing factor. Besides this, health agencies of numerous countries are investing in virtual biobank network
models that help investigators locate biospecimens and data mining from multiple biobanks. This, coupled with
the significant developments in genomics, disease biology, metagenomics, proteomics, bioenergy, and
environmental remediation, are positively influencing the market growth.
Moreover, key players are integrating various advanced technologies with biobanking that assists healthcare
professionals in collecting high-quality and well-annotated human biospecimens and understanding pathogenic
mechanisms. These advanced methods are also being utilized to identify therapeutic targets of coronavirus
disease (COVID-19), which is also creating a positive market outlook across the globe.
Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, expanding at a CAGR
of 5.86% during the forecast period (2023-2028).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/biobanking-market

5. Report
Segmentation
Specimen Type Insights:
• Blood Products
• Solid Tissue
• Cell Lines
• Nucleic Acid
• Others
Biobank Type Insights:
• Population-based Biobanks
• Disease-oriented Biobanks
Application Insights:
• Therapeutics
• Research

6. Report
Segmentation
End-User Insights:
• Academic Institutions
• Pharma and Biotech Companies
Regional Insights:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Brooks Automation Inc.
• Bay Biosciences LLC
• Boca Biolistics
• Ctibiotech
• Cureline Inc.
• Firalis
• Greiner Bio-One International GmbH
• Hamilton Company
• Merck KGaA
• ProteoGenex Inc.
• Thermo Fisher Scientific Inc.
• VWR Corporation (Avantor Inc.)

8. Key Questions
Answered in
the Report
What was the size of the global biobanking
market in 2022?
What is the expected growth rate of the
global biobanking market during 2023-2028?
What are the key factors driving the global
biobanking market?
What has been the impact of COVID-19 on
the global biobanking market?
What is the breakup of the global
biobanking market based on the specimen
type?
What is the breakup of the global
biobanking market based on the biobank
type?

9. Key Questions
Answered in
the Report
What is the breakup of the global biobanking
market based on the application?
What is the breakup of the global biobanking
market based on the end user?
What are the key regions in the global
biobanking market?
Who are the key players/companies in the
global biobanking market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biobanking Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Specimen Type
6.1 Blood Products
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Solid Tissue
6.2.1 Market T rends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Mark et T rends
6.3.2 Mark et Forecast

11. Table of
Contents
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Mark et Forecast
7 Market Breakup by Biobank Type
7.1 Population-based Biobank s
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Disease-oriented Biobank s
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
8 Market Breakup by Application
8.1 T herapeutics
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Research
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
9 Market Breakup by End User
9.1 Academic Institutions
9.1.1 Mark et Trends
9.1.2 Mark et Forecast
9.2 Pharma and Biotech Companies
9.2.1 Mark et Trends
9.2.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/biobanking -market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com